alexa Abstract | PBK/TOPK as a Potential Therapeutic Target in Glioblastoma and Other Malignancies
ISSN: 2168-9547

Molecular Biology: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Short Communication Open Access


A serine/threonine kinase PDZ binding-kinase (PBK) is a member of the mitogen-activated protein kinase (MAPK) kinase (MAPKK) family. This enzyme is also known under the name T-lymphokine-activated killer cell-originated protein kinase (TOPK). PBK was discovered as a factor that binds PDZ2 domain of hDLg (human homologue of the Drosophila Discs-large (Dlg) tumor suppressor protein).This study also demonstrated that the mitotic phosphorylation of PBK is required for its kinase activity.

To read the full article Peer-reviewed Article PDF image | Peer-reviewed Full Article image

Author(s): Biljana Stangeland


PBK/TOPK, Tumor, Cell cycle, Glioblastoma, Glioblastoma initiating cells, shRNA, PBK/TOPK, Tumor, Cell cycle, Glioblastoma, Glioblastoma initiating cells, shRNA

Share This Page

Additional Info

Loading Please wait..
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version